US Stock MarketDetailed Quotes
NGNE Neurogene
- 25.800
- -1.070-3.98%
Close Nov 27 16:00 ET
- 27.000
- +1.200+4.65%
Post 18:11 ET
383.25MMarket Cap-9110P/E (TTM)
27.680High24.600Low530.59KVolume27.140Open26.870Pre Close13.71MTurnover8.01%Turnover RatioLossP/E (Static)14.85MShares74.49052wk High2.79P/B170.93MFloat Cap12.49052wk Low--Dividend TTM6.63MShs Float1115.000Historical High--Div YieldTTM11.46%Amplitude7.500Historical Low25.838Avg Price1Lot Size
Neurogene Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -34.54%-15.56M | -70.40%-15.89M | -59.72%-21.65M | 2.65%-51.42M | -16.97M | -11.57M | -9.33M | -13.56M | -13.84%-52.82M | -46.4M |
| Net income from continuing operations | -38.69%-20.22M | -55.92%-18.49M | -37.98%-16.92M | 34.20%-36.32M | --2.38M | ---14.58M | ---11.86M | ---12.26M | -9.25%-55.19M | ---50.52M |
| Depreciation and amortization | -2.54%807K | -0.73%817K | 0.86%825K | 3.03%3.3M | --828K | --828K | --823K | --818K | 237.91%3.2M | --947K |
| Other non cash items | -399.40%-503K | 310.37%673K | 215.63%505K | -2,680.92%-15.69M | ---16.18M | --168K | --164K | --160K | -10.46%608K | --679K |
| Change In working capital | 57.53%2.56M | -175.65%-879K | -163.32%-6.75M | -49.28%-4.02M | ---4.25M | --1.63M | --1.16M | ---2.56M | -268.97%-2.7M | --1.6M |
| -Change in prepaid assets | 353.81%599K | -535.62%-636K | -81.67%-1.42M | -54.47%326K | --1.2M | ---236K | --146K | ---780K | 136.14%716K | ---1.98M |
| -Change in payables and accrued expense | 28.53%2.61M | -62.81%440K | -193.02%-4.74M | -3.78%-2.91M | ---4.5M | --2.03M | --1.18M | ---1.62M | -165.97%-2.8M | --4.25M |
| -Change in other current assets | --5K | ---51K | --21K | ---764K | ---764K | --0 | --0 | --0 | --0 | ---- |
| -Change in other current liabilities | -284.71%-654K | -278.44%-632K | -271.34%-609K | -11.15%-678K | ---177K | ---170K | ---167K | ---164K | 8.96%-610K | ---670K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -34.54%-15.56M | -70.40%-15.89M | -59.72%-21.65M | 2.65%-51.42M | ---16.97M | ---11.57M | ---9.33M | ---13.56M | -13.84%-52.82M | ---46.4M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -35,224.39%-28.97M | -28,697.56%-23.61M | 103,324.14%29.94M | 1,249.64%25.64M | 25.83M | -82K | -82K | -29K | 87.86%-2.23M | -18.37M |
| Net PPE purchase and sale | -103.66%-167K | -460.98%-460K | -124.14%-65K | 85.61%-321K | ---128K | ---82K | ---82K | ---29K | 87.86%-2.23M | ---18.37M |
| Net investment purchase and sale | ---28.8M | ---23.15M | --30M | --5M | --5M | --0 | --0 | --0 | --0 | ---- |
| Net other investing changes | ---- | ---- | ---- | --20.96M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -35,224.39%-28.97M | -28,697.56%-23.61M | 103,324.14%29.94M | 1,249.64%25.64M | --25.83M | ---82K | ---82K | ---29K | 87.86%-2.23M | ---18.37M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 107.14%131K | 563.95%399K | -6,197.20%-6.52M | 39.01%92.48M | 94.3M | -1.84M | -86K | 107K | 30.29%66.53M | 51.06M |
| Net issuance payments of debt | -20.00%-12K | -166.67%-16K | -120.00%-11K | -2,800.00%-29K | ---8K | ---10K | ---6K | ---5K | ---1K | --0 |
| Net common stock issuance | ---- | ---- | ---- | --92.34M | ---- | ---- | ---- | ---- | --0 | ---- |
| Net preferred stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 30.89%66.46M | --50.78M |
| Proceeds from stock option exercised by employees | 308.57%143K | 1,975.00%415K | 461.61%629K | 130.14%168K | --1K | --35K | --20K | --112K | -74.56%73K | --287K |
| Net other financing activities | --0 | --0 | ---7.14M | ---- | ---- | ---1.86M | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 107.14%131K | 563.95%399K | -6,197.20%-6.52M | 39.01%92.48M | --94.3M | ---1.84M | ---86K | --107K | 30.29%66.53M | --51.06M |
| Net cash flow | ||||||||||
| Beginning cash position | 88.61%111.37M | 119.54%150.48M | 81.32%148.72M | 16.27%82.02M | --45.56M | --59.05M | --68.54M | --82.02M | -16.27%70.54M | --84.25M |
| Current changes in cash | -229.22%-44.4M | -311.88%-39.11M | 113.07%1.76M | 481.14%66.7M | --103.16M | ---13.49M | ---9.5M | ---13.48M | 183.74%11.48M | ---13.71M |
| End cash Position | 46.99%66.97M | 88.61%111.37M | 119.54%150.48M | 81.32%148.72M | --148.72M | --45.56M | --59.05M | --68.54M | 16.27%82.02M | --70.54M |
| Free cash flow | -35.03%-15.73M | -73.80%-16.35M | -59.86%-21.72M | 6.01%-51.74M | ---17.1M | ---11.65M | ---9.41M | ---13.58M | 15.00%-55.05M | ---64.77M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
